Environmental factors as disease accelerators during chronic hepatitis C.
about
Smoking and the outcome of infection.Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infectionMolecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes.Age and ethnicity in cirrhosis.Endocannabinoid signaling at the periphery: 50 years after THC.A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India.Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy.The impact of lifetime drug use on hepatitis C treatment outcomes in insured members of an integrated health care planHealthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.Effect of smoking on survival of patients with hepatocellular carcinoma.The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.Impact of common risk factors of fibrosis progression in chronic hepatitis C.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection.A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.Hepatitis C virus infection in primary care: survey of registered nurses' knowledge and access to information.Personality, Coping, and Well-Being for People Living with Chronic Hepatitis C.Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
P2860
Q27687123-0F147ADD-DE9D-4970-95E5-00702C451BE8Q30429470-93262A59-AA2A-4D53-A684-5BFF4B5108AEQ33904205-5B0346E4-2B75-477D-B113-ED4F5AE01FE2Q33959178-567FB7D3-BCAB-4ABA-9F36-779EB46FDF4FQ34081261-68676F30-3178-4FFA-A466-D78EB86805D4Q34088634-6FDDF8ED-938E-4AE2-9758-702FBF27C26CQ34231825-570C22C0-AAFB-43B9-8D15-5DB321F0927AQ35572176-D1C1AEEF-E1B8-48E3-A2D7-DEE32ED910CFQ35579175-8E54620D-338A-4B8A-B7F9-B357315ED0C3Q36026554-8675E5DC-C0D4-48D1-9ED5-535B15FCFF9EQ37089469-C6EFAB45-A66F-4C08-84E6-ACAAF36B30BDQ37279232-43A71876-CB74-4948-B64A-1447B9CFF409Q37463091-EF83B657-EDCB-46D9-95FA-CB6B214C4AD3Q38710078-69131600-3CD0-4536-972C-8B0BEE5F5F0EQ38806977-4AB562F4-2DAA-4AD5-9844-6992F2F3AA68Q40037618-8B5F4474-49EA-4080-8876-8E09593AB877Q41741892-E5A16415-53AE-46DC-807E-0EB2623B2C20Q42280296-C22F361C-08D9-4CFC-A728-24CD6A472981Q45356172-EC2A5552-952F-444D-8687-E54A6F1D8E11Q45361290-0CFDD90F-EF1D-40FA-9612-74D8B430FA9AQ45371534-EC4EE238-B7C1-4F29-85BE-33B9D5D7D45AQ48028755-E97924CB-55D3-42A1-940E-57B49B844383Q50533517-FB23E50B-7882-4862-942A-C5C5B3B74EDD
P2860
Environmental factors as disease accelerators during chronic hepatitis C.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Environmental factors as disease accelerators during chronic hepatitis C.
@en
Environmental factors as disease accelerators during chronic hepatitis C.
@nl
type
label
Environmental factors as disease accelerators during chronic hepatitis C.
@en
Environmental factors as disease accelerators during chronic hepatitis C.
@nl
prefLabel
Environmental factors as disease accelerators during chronic hepatitis C.
@en
Environmental factors as disease accelerators during chronic hepatitis C.
@nl
P1476
Environmental factors as disease accelerators during chronic hepatitis C.
@en
P2093
Ariane Mallat
Christophe Hezode
P304
P356
10.1016/J.JHEP.2008.01.004
P577
2008-01-28T00:00:00Z